Aurolife FDA Wednesday, April 11, 2012 0.00 Neutral

FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Aurolife Pharma, LLC

Aurolife Pharma, LLC received FDA approval for its Abbreviated New Drug Application for hydrocodone bitartrate and acetaminophen tablets on a recent date, likely increasing generic competition in the pain management market and impacting pricing strategies for brand-name manufacturers.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day